Testing a new kind of brain scan that looks at how tumors use sugar
Official title: Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study checks whether a new scan can show how a brain tumor uses sugar for fuel.
Read our full plain-language summary
What the trial team says
The purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors. To accomplish this, the investigators propose obtaining image-guided measures of tissue pH and biopsied tissue in tumor areas selected for bulk resection surgery. Investigators will then correlate the imaging measurements with pH, RNA expression, protein expression, and bioenergetics measurements of key glycolytic enzymes.
Key facts
- Registry number
- NCT06059690
- Stage of testing
- Phase 1/Phase 2
- Conditions studied
- Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor
Where it is running
This trial lists 1 site.
-
California
- University of California at Los Angeles (Los Angeles)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.